Freeing up generics, will Australia follow the EC
24 augustus 2009
Last month's final report of the European Commission Pharmaceutical Sector Inquiry, and parallel developments in the US, indicate an increasingly tough attitude by international regulators to attempts by originator pharma companies to hold back generics from market entry.
Bron: Pharma in Focus (registratie verplicht)
| < Vorige | Volgende > |
|---|
